Dendritic cell differentiation is controlled at least by STAT3-binding lncRNA-dendritic cells (lnc-DC) in humans [130]; in breast cancer, lnc-DC can inhibit tamoxifen-induced apoptosis by upregulating antiapoptotic (Bcl2 and Bcl-xL). Here, BCL2 is linked to breast carcinoma.